Among all, the PI3K/AKT/mTOR pathway is particularly interesting because it is constitutively activated in a significant proportion of patients with HCC and it is associated with a more aggressive tumor progression and shorter survival [5]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.